BioCentury | Oct 25, 2019
Tools & Techniques

NASH: how non-invasive biomarkers promise to displace biopsies

...thought to indicate the extent of fibrogenesis in the liver. The biomarker was identified by Nordic Bioscience A/S...
BioCentury | Oct 20, 2018
Product Development

CVOT damage in diabetes

...Pharmaceuticals Inc. (NASDAQ:LXRX) Amylin receptor; calcitonin receptor Other hormone signaling pathway Unknown DACRA-089 (KBP-089) Peptide Nordic Bioscience A/S...
BioCentury | Jun 23, 2017
Company News

KeyBioscience grants Lilly rights to Type II diabetes platform

...The KeyBioscience AG subsidiary of Nordic Bioscience A/S (Herlev, Denmark) granted Eli Lilly and Co. (NYSE:LLY) worldwide rights...
...calcitonin receptors. Lilly declined to disclose additional details, and Nordic Bioscience did not respond to inquiries. Nordic Bioscience A/S...
...Herlev, Denmark Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic Alicia Parker Eli Lilly and Co. Nordic Bioscience A/S Amylin...
BioCentury | Apr 21, 2017
Company News

Bristol-Myers Squibb, Nordic Bioscience deal

...Bristol-Myers Squibb and Nordic Bioscience partnered to develop translational biomarkers and diagnostics to detect non-alcoholic steatohepatitis (NASH...
...Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Nordic Bioscience A/S , Herlev, Denmark Business: Diagnostic Julian Zhu Bristol-Myers Squibb Co. Nordic Bioscience A/S...
BioCentury | Nov 17, 2016
Clinical News

SB-061: Completed Ph I/IIa enrollment

...2 intra-articular injections of SB-061. Last year, Symic and Nordic partnered to develop Symic's SB-061. Nordic Bioscience A/S...
...rating scale (NRS) of pain Status: Completed Phase I/IIa enrollment Milestone: Phase I/IIa data (1H17) Alex Himes SB-061 Nordic Bioscience A/S Symic...
BioCentury | Aug 15, 2016
Finance

Serving returns

...SB-061 to treat mild to moderate osteoarthritis of the knee. The product is partnered with Nordic Bioscience A/S...
...NYSE:MDT), Dublin, Ireland NantKwest Inc. (NASDAQ:NK), Cardiff-by-the-Sea, Calif. New WuXi Life Science Ltd., Shanghai, China Nordic Bioscience A/S...
BioCentury | Jul 11, 2016
Clinical News

SB061: Phase I/II started

...Symic and Nordic Bioscience began the double-blind, placebo-controlled, Estonian Phase I/II MODIFY-OA trial to evaluate intra-articular injections...
...of SB061 in about 90 patients. In 2015, Symic and Nordic partnered to develop SB061. Nordic Bioscience A/S...
BioCentury | Apr 7, 2016
Product R&D

Branching out

...with expertise in the target disease indications. Symic has a business partnership with the CRO Nordic Bioscience A/S...
...See Table: Biocentury Product Profile) Companies and Institutions Mentioned Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), Cambridge, Mass. Nordic Bioscience A/S...
BioCentury | Dec 7, 2015
Company News

Charles River, Gruenenthal, Nordic Bioscience deal

...Argenta Discovery 2009 Ltd. partnered with Gruenenthal and Nordic Bioscience to develop preclinical and clinical assays to...
...therapies. Argenta will provide preclinical models, primary cell-based assays, in vivo pharmacology and fibrosis research. Nordic Bioscience...
...disease subsegments, and Gruenenthal will provide expertise on drug discovery and development and coordinate activities. Nordic Bioscience...
BioCentury | Jan 5, 2015
Emerging Company Profile

Mimicking proteoglycans

...2012 by Alyssa Panitch, John Paderi and Kate Stuart University collaborators: Purdue University Corporate partners: Nordic Bioscience A/S...
Items per page:
1 - 10 of 58
BioCentury | Oct 25, 2019
Tools & Techniques

NASH: how non-invasive biomarkers promise to displace biopsies

...thought to indicate the extent of fibrogenesis in the liver. The biomarker was identified by Nordic Bioscience A/S...
BioCentury | Oct 20, 2018
Product Development

CVOT damage in diabetes

...Pharmaceuticals Inc. (NASDAQ:LXRX) Amylin receptor; calcitonin receptor Other hormone signaling pathway Unknown DACRA-089 (KBP-089) Peptide Nordic Bioscience A/S...
BioCentury | Jun 23, 2017
Company News

KeyBioscience grants Lilly rights to Type II diabetes platform

...The KeyBioscience AG subsidiary of Nordic Bioscience A/S (Herlev, Denmark) granted Eli Lilly and Co. (NYSE:LLY) worldwide rights...
...calcitonin receptors. Lilly declined to disclose additional details, and Nordic Bioscience did not respond to inquiries. Nordic Bioscience A/S...
...Herlev, Denmark Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic Alicia Parker Eli Lilly and Co. Nordic Bioscience A/S Amylin...
BioCentury | Apr 21, 2017
Company News

Bristol-Myers Squibb, Nordic Bioscience deal

...Bristol-Myers Squibb and Nordic Bioscience partnered to develop translational biomarkers and diagnostics to detect non-alcoholic steatohepatitis (NASH...
...Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Nordic Bioscience A/S , Herlev, Denmark Business: Diagnostic Julian Zhu Bristol-Myers Squibb Co. Nordic Bioscience A/S...
BioCentury | Nov 17, 2016
Clinical News

SB-061: Completed Ph I/IIa enrollment

...2 intra-articular injections of SB-061. Last year, Symic and Nordic partnered to develop Symic's SB-061. Nordic Bioscience A/S...
...rating scale (NRS) of pain Status: Completed Phase I/IIa enrollment Milestone: Phase I/IIa data (1H17) Alex Himes SB-061 Nordic Bioscience A/S Symic...
BioCentury | Aug 15, 2016
Finance

Serving returns

...SB-061 to treat mild to moderate osteoarthritis of the knee. The product is partnered with Nordic Bioscience A/S...
...NYSE:MDT), Dublin, Ireland NantKwest Inc. (NASDAQ:NK), Cardiff-by-the-Sea, Calif. New WuXi Life Science Ltd., Shanghai, China Nordic Bioscience A/S...
BioCentury | Jul 11, 2016
Clinical News

SB061: Phase I/II started

...Symic and Nordic Bioscience began the double-blind, placebo-controlled, Estonian Phase I/II MODIFY-OA trial to evaluate intra-articular injections...
...of SB061 in about 90 patients. In 2015, Symic and Nordic partnered to develop SB061. Nordic Bioscience A/S...
BioCentury | Apr 7, 2016
Product R&D

Branching out

...with expertise in the target disease indications. Symic has a business partnership with the CRO Nordic Bioscience A/S...
...See Table: Biocentury Product Profile) Companies and Institutions Mentioned Momenta Pharmaceuticals Inc. (NASDAQ:MNTA), Cambridge, Mass. Nordic Bioscience A/S...
BioCentury | Dec 7, 2015
Company News

Charles River, Gruenenthal, Nordic Bioscience deal

...Argenta Discovery 2009 Ltd. partnered with Gruenenthal and Nordic Bioscience to develop preclinical and clinical assays to...
...therapies. Argenta will provide preclinical models, primary cell-based assays, in vivo pharmacology and fibrosis research. Nordic Bioscience...
...disease subsegments, and Gruenenthal will provide expertise on drug discovery and development and coordinate activities. Nordic Bioscience...
BioCentury | Jan 5, 2015
Emerging Company Profile

Mimicking proteoglycans

...2012 by Alyssa Panitch, John Paderi and Kate Stuart University collaborators: Purdue University Corporate partners: Nordic Bioscience A/S...
Items per page:
1 - 10 of 58